Accession PRJCA005787
Title Single-cell analysis reveals cellular heterogeneity and novel therapeutic targets in relapsed/refractory AML
Relevance Medical
Data types Transcriptome or Gene expression
Organisms Homo sapiens
Description Chemoresistance and relapse are the leading cause of poor outcomes for patients with acute myeloid leukemia (AML). The high intratumoral heterogeneity (ITH) and the co-evolution between leukemia cells and the microenvironment are the main reasons for drug resistance. Utilizing single-cell RNA sequencing (scRNA-seq), we dissect the cellular states and the immune microenvironment of bone marrow from primary refractory or short-term relapsed AML patients.
Sample scope Single cell
Release date 2022-10-25
Publication
PubMed ID Article title Journal name DOI Year
36543880 Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia Leukemia 10.1038/s41375-022-01789-6 2022
38807380 Identification of cell surface markers for acute myeloid leukemia prognosis based on multi-model analysis Journal of Biomedical Research 10.7555/JBR.38.20240065 2024
Grants
Agency program Grant ID Grant title
National Natural Science Foundation of China (NSFC) Young Scientists Fund 32000497
Submitter Wang Qianghu (wangqh@njmu.edu.cn)
Organization Nanjing Medical University
Submission date 2021-07-08

Project Data

Resource name Description
BioSample (13)  show -